劳力性热射病患者早期死亡风险的评估指标分析

张玲琴, 谢建刚, 赵霄君, 等. 劳力性热射病患者早期死亡风险的评估指标分析[J]. 临床急诊杂志, 2024, 25(4): 192-197. doi: 10.13201/j.issn.1009-5918.2024.04.007
引用本文: 张玲琴, 谢建刚, 赵霄君, 等. 劳力性热射病患者早期死亡风险的评估指标分析[J]. 临床急诊杂志, 2024, 25(4): 192-197. doi: 10.13201/j.issn.1009-5918.2024.04.007
ZHANG Lingqin, XIE Jiangang, ZHAO Xiaojun, et al. Preliminary study on predictors of early death risk in patients with exertional heat stroke[J]. J Clin Emerg, 2024, 25(4): 192-197. doi: 10.13201/j.issn.1009-5918.2024.04.007
Citation: ZHANG Lingqin, XIE Jiangang, ZHAO Xiaojun, et al. Preliminary study on predictors of early death risk in patients with exertional heat stroke[J]. J Clin Emerg, 2024, 25(4): 192-197. doi: 10.13201/j.issn.1009-5918.2024.04.007

劳力性热射病患者早期死亡风险的评估指标分析

  • 基金项目:
    陕西省自然科学基金面上项目(No:2022JM-566、2023JC-YB-686)
详细信息

Preliminary study on predictors of early death risk in patients with exertional heat stroke

More Information
  • 目的 通过对劳力性热射病患者入院24 h检查结果进行统计学分析,寻找快速鉴别短期预后的指标。方法 将我院2016年1月1日至2022年12月31日收治的81例热射病患者,按28 d预后结果分为存活组(58例)和死亡组(23例)。对2组间基础资料、检验结果、衍生比值进行比较,并进行多因素Cox回归分析、Kaplan-Meier生存曲线、受试者工作特征曲线分析,从而寻找判断短期预后的相关指标。结果 2组间各项指标比较发现,29个指标差异有统计学意义(P<0.05)。多因素Cox回归分析提示,谷草转氨酶/谷丙转氨酶比值(P=0.02)和血小板分布宽度(P=0.04)是影响热射病患者预后的独立危险因素。Kaplan-Meier生存曲线发现,谷草转氨酶/谷丙转氨酶比值与患者的生存状况具有显著相关性(P < 0.001),而血小板分布宽度与患者的生存状况无相关性(P>0.05)。受试者工作特征曲线分析显示,谷草转氨酶/谷丙转氨酶比值预测劳力性热射病患者预后的曲线下面积为0.738。结论 谷草转氨酶/谷丙转氨酶比值可作为预测劳力性热射病早期死亡风险的指标,用于指导急诊科医生分层治疗。
  • 加载中
  • 图 1  劳力性热射病预后影响因素的森林图

    图 2  Kaplan-Meier生存曲线分析

    图 3  AST/ALT、PDW预测劳力性热射病患者短期预后的ROC曲线

    表 1  2组间基线资料、生命体征、血气分析结果比较

    指标 存活组(58例) 死亡组(23例) t/F P
    男/例(%) 39(67.24) 21(91.30) 5.66 0.02
    年龄/岁 23.00(21.00,26.75) 32.00(23.00,40.00) 3.84 <0.01
    平均动脉压/mmHg 85.67(78.83,88.83) 81.67(62.33,88.50) -1.54 0.14
    体温/℃ 37.64±1.26 38.50±1.70 2.49 0.02
    呼吸/(次/min) 23.09±7.22 26.04±9.25 1.53 0.13
    心率/(次/min) 93.31±22.43 125.13±29.21 5.27 <0.01
    氧分压/mmHg 133.02±36.29 92.57±32.92 -4.60 <0.01
    二氧化碳分压/mmHg 29.68±7.76 30.35±7.52 0.35 0.72
    二氧化碳含量/(mmol/L) 22.12±4.13 21.99±5.68 -0.11 0.91
    pH值 7.37(7.17,7.63) 7.33(6.23,7.62) -1.98 0.06
    1 mmHg=0.133 kPa。
    下载: 导出CSV

    表 2  2组间血生化指标和衍生比值结果比较

    指标 存活组(58例) 死亡组(23例) t/F P
    血常规指标
      白细胞计数/(×109/L) 7.82(3.00,20.90) 11.50(4.41,28.78) 2.68 0.13
      NEU/(×109/L) 5.32(0.75,17.48) 8.36(2.04,23.89) 3.04 0.01
      淋巴细胞计数/(×109/L) 1.79(0.43,4.12) 0.84(0.19,9.18) -0.18 0.86
      红细胞计数/(×1012/L) 5.01(3.91,5.89) 4.95(3.12,5.60) -2.01 0.54
      RDW/% 41.05(36.60,50.00) 41.50(37.20,53.20) 2.23 0.03
      血红蛋白/(g/L) 148.50(111.00,179.00) 145.00(87.00,191.00) 4.63 0.05
      红细胞压积/% 0.43(0.34,0.50) 0.41(0.29,0.55) -1.04 0.31
      PLT/(×109/L) 208.44±60.17 118.04±84.18 -5.42 <0.01
      PDW/% 12.89±2.55 14.72±4.57 2.30 0.02
    炎症指标
      IL-6/(ng/mL) 5.23(3.78,7.45) 46.30(32.61,106.25) 2.31 0.01
      PCT/(ng/mL) 0.05(0.02,0.87) 3.20(0.07,100.00) 2.58 0.02
    凝血指标
      PT/s 11.40(9.70,19.30) 14.10(7.20,120.00) 3.21 <0.01
      APTT/s 26.70(18.30,40.20) 29.50(17.00,119.40) 2.66 0.01
      INR 0.99(0.85,1.83) 1.34(0.89,6.24) 4.15 <0.01
      D-D/(μg/mL) 0.25(0.03,58.00) 3.24(0.41,47.74) 2.43 0.02
    心功能指标
      Lac/(mmol/L) 2.75±3.19 5.03±4.18 2.64 0.01
      B型钠尿肽/(pg/mL) 25.45(15.18,44.41) 812.00(63.82,2 812.00) 1.96 0.06
      肌酸激酶同工酶/(IU/L) 3.40(1.43,8.05) 48.20(5.10,100.40) 1.18 0.25
      肌钙蛋白/(IU/L) 0.02±0.05 16.41±68.10 1.15 0.26
      MB/(IU/L) 53.38(28.10,97.50) 748.00(172.10,3 514.00) 4.25 <0.01
      LDH/(IU/L) 206.00(184.00,234.50) 503.00(331.00,1 331.00) 2.37 0.03
    肝功能指标
      总胆红素/(μmol/L) 14.05(3.78,53.80) 19.00(7.60,161.60) 2.65 0.14
      DBIL/(μmol/L) 6.55(1.70,11.70) 8.40(1.50,111.60) 4.34 <0.01
      ALB/(g/L) 45.40±4.70 39.21±10.37 -2.75 0.01
      球蛋白/(g/L) 28.91±4.39 27.05±6.40 -1.29 0.21
      AST/(IU/L) 24.50(9.00,91.00) 123.00(12.00,6 658.00) 4.09 <0.01
      ALT/(IU/L) 19.00(6.00,192.00) 45.00(7.00,6 552.00) 3.62 <0.01
      ALB/球蛋白 1.61±0.31 1.53±0.42 -0.84 0.46
    肾功能指标
      Cr/(μmol/L) 96.00(61.00,169.00) 170.00(62.00,494.00) 3.96 <0.01
      BUN/(mmol/L) 5.30±1.88 8.84±5.84 4.14 <0.01
      尿酸/(μmol/L) 407.19±127.81 492.39±190.31 1.98 0.06
    衍生比值
      血红蛋白/RDW 3.58±0.51 3.29±0.70 -1.82 0.08
      RDW/ALB 0.91±0.11 1.18±0.36 5.17 <0.01
      RDW/PLT 0.20(0.12,1.61) 0.46(0.12,11.05) 2.79 0.01
      D-D/PLT 1.30×10-3(9.60×10-5,0.24) 0.05(1.20×10-3,2.42) 3.62 <0.01
      D-D/ALB 6.00×10-3(5.80×10-4,1.19) 0.07(9.60×10-3,1.57) 3.65 <0.01
      D-D/B型钠尿肽 9.30×10-3(8.30×10-4,4.52) 7.30×10-3(2.80×10-4,0.81) -0.62 0.53
      D-D/肌钙蛋白 28.25(1.39,11 600.00) 12.58(4.20×10-3,285.00) -1.13 0.26
      PT/INR 12.11±2.54 12.25±5.09 0.13 0.90
      AST/ALT 1.26±0.63 1.86±0.94 2.81 0.01
    下载: 导出CSV

    表 3  AST/ALT、PDW预测劳力性热射病患者短期预后的ROC曲线分析

    项目 AST/ALT PDW
    曲线下面积 0.738 0.620
    最佳截断值 1.36 15.40%
    灵敏度/% 73.91 34.78
    特异度/% 75.86 87.93
    95%CI 0.61~0.87 0.48~0.77
    下载: 导出CSV
  • [1]

    Peiris AN, Jaroudi S, Noor R. Heat Stroke[J]. JAMA, 2017, 318(24): 2503. doi: 10.1001/jama.2017.18780

    [2]

    Bouchama A, Abuyassin B, Lehe C, et al. Classic and exertional heatstroke[J]. Nat Rev Dis Primers, 2022, 8(1): 8. doi: 10.1038/s41572-021-00334-6

    [3]

    Leyk D, Hoitz J, Becker C, et al. Health Risks and Interventions in Exertional Heat Stress[J]. Dtsch Arztebl Int, 2019, 116(31-32): 537-544.

    [4]

    于超平, 李俊杰, 尹文. 热射病相关SIRS研究进展[J]. 临床急诊杂志, 2021, 22(4): 287-291. https://lcjz.whuhzzs.com/article/doi/10.13201/j.issn.1009-5918.2021.04.014?viewType=HTML

    [5]

    张玲琴, 谢建刚, 王倩梅, 等. 利用转录组测序生物信息学初步探讨热射病预后关键基因[J]. 中国急救医学, 2022, 42(1): 64-67. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJJY202201013.htm

    [6]

    Laitano O, Leon LR, Roberts WO, et al. Controversies in exertional heat stroke diagnosis, prevention, and treatment[J]. J Appl Physiol, 2019, 127(5): 1338-1348. doi: 10.1152/japplphysiol.00452.2019

    [7]

    Knoll JM, Knight LR, Quiroz D, et al. Variation in Clinical Presentations and Outcomes of Heat Stroke Victims in the Mass-Casualty Setting[J]. J Emerg Med, 2019, 57(6): 866-870. doi: 10.1016/j.jemermed.2019.08.024

    [8]

    Yang MM, Wang L, Zhang Y, et al. Establishment and effectiveness evaluation of a scoring system for exertional heat stroke by retrospective analysis[J]. Mil Med Res, 2020, 7(1): 40.

    [9]

    Garcia CK, Renteria LI, Leite-Santos G, et al. Exertional heat stroke: pathophysiology and risk factors[J]. BMJ Med, 2022, 1(1): e000239. doi: 10.1136/bmjmed-2022-000239

    [10]

    Hirschhorn R, DadeMatthews O, Sefton J. Exertional Heat Stroke Knowledge and Management among Emergency Medical Service Providers[J]. Int J Environ Res Public Health, 2021, 18(9): 5016. doi: 10.3390/ijerph18095016

    [11]

    DeGroot DW, O'Connor FG, Roberts WO. Exertional heat stroke: an evidence based approach to clinical assessment and management[J]. Exp Physiol, 2022, 107(10): 1172-1183. doi: 10.1113/EP090488

    [12]

    Giersch GEW, Garcia CK, Stachenfeld NS, et al. Are there sex differences in risk for exertional heat stroke? A translational approach[J]. Exp Physiol, 2022, 107(10): 1136-1143. doi: 10.1113/EP090402

    [13]

    Belval LN, Giersch GEW, Adams WM, et al. Age-and Sex-Based Differences in Exertional Heat Stroke Incidence in a 7-Mile Road Race[J]. J Athl Train, 2020, 55(12): 1224-1229. doi: 10.4085/1062-6050-539-19

    [14]

    May JE, Marques MB, Reddy VVB, et al. Three neglected numbers in the CBC: The RDW, MPV, and NRBC count[J]. Cleve Clin J Med, 2019, 86(3): 167-172. doi: 10.3949/ccjm.86a.18072

    [15]

    Zheng YY, Wang L, Shi Q. Mean platelet volume(MPV)and platelet distribution width(PDW)predict clinical outcome of acute ischemic stroke: A systematic review and meta-analysis[J]. J Clin Neurosci, 2022, 101: 221-227. doi: 10.1016/j.jocn.2022.05.019

    [16]

    Haybar H, Pezeshki SMS, Saki N. Evaluation of complete blood count parameters in cardiovascular diseases: An early indicator of prognosis?[J]. Exp Mol Pathol, 2019, 110: 104267. doi: 10.1016/j.yexmp.2019.104267

    [17]

    Guo F, Zhu X, Qin X. Platelet Distribution Width in Hepatocellular Carcinoma[J]. Med Sci Monit, 2018, 24: 2518-2523. doi: 10.12659/MSM.909474

    [18]

    Li C, Zhang H, Li S, et al. Prognostic Impact of Inflammatory Markers PLR, LMR, PDW, MPV in Medullary Thyroid Carcinoma[J]. Front Endocrinol(Lausanne), 2022, 13: 861869. doi: 10.3389/fendo.2022.861869

    [19]

    Yang MH, Duan CJ, Liu SS, et al. Application of NLRP3 Inflammasome-related Modulators in Sepsis[J]. J Explor Res Pharmaco, 2022, 7(2): 104-111. doi: 10.14218/JERP.2021.00055

    [20]

    Yin H, Wu M, Lu Y, et al. HMGB1-activatied NLRP3 inflammasome induces thrombocytopenia in heatstroke rat[J]. PeerJ, 2022, 10: e13799. doi: 10.7717/peerj.13799

    [21]

    Botros M, Sikaris KA. The de ritis ratio: the test of time[J]. Clin Biochem Rev, 2013, 34(3): 117-130.

    [22]

    Aksoy MNM, Turna F, Sahin I, et al. Is AST/ALT Ratio a Predictor of In-hospital Mortality in Pulmonary Embolism Patients?[J]. J Coll Physicians Surg Pak, 2022, 32(2): 171-176. doi: 10.29271/jcpsp.2022.02.171

    [23]

    Liu H, Zha X, Ding C, et al. AST/ALT Ratio and Peripheral Artery Disease in a Chinese Hypertensive Population: A Cross-Sectional Study[J]. Angiology, 2021, 72(10): 916-922. doi: 10.1177/00033197211004410

    [24]

    Liu Y, Zhao P, Cheng M, et al. AST to ALT ratio and arterial stiffness in non-fatty liver Japanese population: a secondary analysis based on a cross-sectional study[J]. Lipids Health Dis, 2018, 17(1): 275. doi: 10.1186/s12944-018-0920-4

    [25]

    Geng Y, Ma Q, Liu YN, et al. Heatstroke induces liver injury via IL-1β and HMGB1-induced pyroptosis[J]. J Hepatol, 2015, 63(3): 622-633. doi: 10.1016/j.jhep.2015.04.010

    [26]

    Li P, Yang L, Liu R, et al. The value of the exertional heat stroke score for the prognosis of patients with exertional heat stroke[J]. Am J Emerg Med, 2021, 50: 352-355. doi: 10.1016/j.ajem.2021.08.036

    [27]

    Yokoyama K, Kaneko T, Ito A, et al. Sequential organ failure assessment score as a predictor of the outcomes of patients hospitalized for classical or exertional heatstroke[J]. Sci Rep, 2022, 12(1): 16373. doi: 10.1038/s41598-022-20878-1

  • 加载中

(3)

(3)

计量
  • 文章访问数:  631
  • PDF下载数:  64
  • 施引文献:  0
出版历程
收稿日期:  2023-12-26
刊出日期:  2024-04-10

目录